TTrialPathMatch Me to Trials
← Back to trials
RecruitingObstructive Sleep ApneaPremature Ventricular Contraction (PVC)Atrial Fibrillation (AF)

Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation

Eligible age

21+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Whereas the available evidence mostly supports chronic sleep disruption as a risk factor for incident AF, less is known about the near-term risk of a discrete atrial fibrillation (AF) episode following a night of disrupted or poor-quality sleep. This prospective, randomized, case-crossover study aims to examine the acute effects of sleep disruption on clinically relevant cardiac ectopy pertinent to AF.

Sponsor: University of California, San Francisco

You may qualify if…

  • Are age 21 years or older
  • Have a HGNS device implanted for obstructive sleep apnea and followed up at UCSF Health
  • Are willing to abstain from using the upper airway stimulation device for no more than two consecutive days as instructed over the 14-day trial period
  • Able and willing to provide written informed consent

You may not qualify if…

  • Currently pregnant or trying to get pregnant
  • Are currently taking class 1 or 3 anti-arrhythmic medications
  • Have a history of permanent AF or expected to have continuous AF throughout the study period
  • Have congenital heart disease
  • Ventricular pacing \>40%
  • Are unable to read or sign to provide informed consent

Where it's recruiting

California

San Francisco

Source: ClinicalTrials.gov · NCT07220525 · last updated 2026-01-23

Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation · TrialPath